TECX · Tectonic Therapeutic, Inc.

Tectonic Therapeutic appointed Jessica Chutter to its Board of Directors and Audit Committee, effective June 8, 2026. Ms. Chutter brings over four decades of healthcare investment banking experience, having spent her career at Morgan Stanley where she served as Managing Director and Vice Chair of Healthcare Investment Banking. Her expertise in capital markets and strategic transactions is expected to support Tectonic as it advances its clinical-stage pipeline. As a non-employee director, she will receive standard compensation including an annual cash retainer of $40,000, an additional $7,500 for Audit Committee service, and an initial option award of 20,400 shares vesting over three years. The appointment fills a board vacancy and adds independent oversight.